Leukemia cancer treatment in India for children primarily includes stem-cell therapy, radiation, and chemotherapy. However, research shows that while the survival rate of some types of leukemia is over 90%, there are still some children who do not respond to these standard treatments and experience relapse. Therefore, to bypass the side effects of chemotherapy and radiation therapy, we are continuously working out new childhood leukemia research in the search for less toxic treatments.

Today researchers and our best blood cancer doctor in Noida are concentrating more on the latest findings on the treatment of childhood leukemia and focusing on immunotherapies and Newer chemotherapy drugs. Fortunately, studies show that immunotherapy with blinatumomab is less aggressive chemotherapy.

Recent studies on the causes and prevention of childhood leukemia 

Although statistics show that doctors have found changes in a gene called FLT3 in about 10% of children with leukemia, researchers have found that both genetics and environmental exposures might be the reason for leukemia in children. Some scientists found that leukemia cells can develop because of gene changes even before birth and at an early age. Moreover, other studies show how being exposed to certain germs (particularly viruses) might affect the immune system of the patients in such a way that it leads to gene change, which later causes leukemia. 

By the in-depth study of the blood cancer update and the latest innovation in the field of blood cancers, doctors today are using the newest treatments that show promising results.

Immunotherapy

Immunotherapies today are even working on those children who have not responded well to other treatment options. These immune-boosting treatments help improve a child’s immune system and help fight leukemia. Further, results from clinical trials show that children who had a higher risk of relapse had experienced fewer severe side-effects when they are treated with the immunotherapy drug blinatumomab.

Chimeric antigen receptor (CAR) T-cell therapy

In (CAR) T-cell therapy, doctors are removing and genetically altering the immune cells called T cells from the patient’s blood to help them attack leukemia cells. In this technique, the T cells are then given back into the patient’s blood to fight the leukemia cells. Best oncologist in Delhi and all over the world are still studying how to use this CAR T-cell therapy for better results. Fortunately, the clinical trials have shown encouraging results, and in many patients, leukemia could not be detected after treatment.

Monoclonal antibody therapy

Every leukemia cancer doctor in Noida today is looking forward to using Monoclonal antibody therapy to fight infections and diseases like leukemia in children. Monoclonal antibodies are man-made versions of antibodies that are designed to attack protein on the surface of leukemia cells, for example, blinatumomab (Blincyto), a monoclonal antibody that attacks two different proteins.

Latest treatments and Clinical trials

Several studies on leukemia cancer in India show that genetics play a massive role in the development of leukemia cells. Therefore, doctors are studying the changes in the gene and chromosome inside the bone marrow stem cells to understand what causes them to develop into leukemia cells. Further, by understanding these changes, the best cancer doctor in Delhi NCR determines the treatment options that can be the most effective for children. 

As tests like the polymerase chain reaction (PCR) today can identify leukemia cells based on their chromosome changes, doctors are using these for patients. Besides, doctors are also starting to use tests called next-generation sequencing (NGS) tests, which are more advanced and useful in determining whether the leukemia cells have been destroyed or not and the chances of relapse.

Clinical trials to ensure up-to-date care

Based on the on-going studies, with our top lymphoma cancer doctor in Noida, we are focusing on new treatments such as antibodies & new chemotherapy that will hopefully increase the survival and cure of leukemia in children. 

Further, different types of targeted drugs like FLT3 inhibitors, IDH inhibitors, and BCL-2 inhibitors are now being tested for use in children. The main aim of these clinical trials is to find satisfactory ways of reducing the side effects and improve the quality of life in childhood Leukemia patients.

Lastly, it is evident that what works for one patient may not be the best one for another patient. Therefore it is vital to consult a cancer specialist for proper diagnosis and treatment. So, you can book an appointment with our specialist, Dr. Manish Singhal, at Cancer consult India and get the best cancer treatment.

ALSO READ: Blood Cancer Patients Are More Vulnerable To The Effects Of COVID-19 Infection